SynthesisBMC women's health2018

Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.

Yan Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.